Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00902804136 · Dead
| Application Number | UK00902804136 |
| Status | Dead |
| Owner | Pacira Pharmaceuticals, Inc. |
| Filed | 2002-07-16 |
| Registered | 2003-12-18 |
| Renewal Due | 2022-07-16 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
DEPOCYTE has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; pharmaceuticals containing or comprising agents for treating meningitis, haematological malignancies and tumours.
Custom manufacturing services; manufacture for others of pharmaceutical products.
Medical, surgical, veterinary, scientific and industrial research and development services; product development, design and engineering services; carrying out feasibility studies relating to pharmaceuticals; testing of pharmaceuticals; development of pharmaceutical products; pharmaceutical formulation services; intellectual property licence granting and exploitation services; obtaining pharmaceutical and medicinal and regulatory product licences for others.
Provision of information relating to medical, surgical and veterinary matters on line from a computer database or over the Internet.
'DEPOCYTE' is a dead trademark on the UK IPO register, owned by Pacira Pharmaceuticals, Inc.. The application (UK00902804136) was filed on 16 July 2002 and registered on 18 December 2003. The registration is set to expire on 16 July 2022.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 40 (treatment of materials & manufacturing services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Kilburn & Strode LLP.
UK trademark UK00902804136 for the mark 'DEPOCYTE' in Class 5, 40, 42, 44 is recorded on the UK IPO register as owned by Pacira Pharmaceuticals, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00902804136 for the mark 'DEPOCYTE' as dead.
UK trademark UK00902804136 for the mark 'DEPOCYTE' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 40 (treatment of materials & manufacturing services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceuticals containing or comprising agents for treating meningitis, haematological malignancies and tumours. | Class 40: Custom manufacturing services; manufacture for others of pharmaceutical products. | Class 42: Medical, surgical, veterinary, scientific and industrial re…
UK trademark UK00902804136 for the mark 'DEPOCYTE' was filed at the UK IPO on 16 July 2002 and registered on 18 December 2003.
UK trademark UK00902804136 for the mark 'DEPOCYTE' is currently recorded as valid until 16 July 2022, at which point it will need to be renewed with the UK IPO to remain in force.
Kilburn & Strode LLP is listed as the attorney / representative of record for UK trademark UK00902804136 for the mark 'DEPOCYTE' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.